Exelixis reported $301.73M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Akebia Therapeutics AKBA:US USD 187.96M 45.72M
Amgen AMGN:US USD 15.69B 1.36B
AstraZeneca AZN:LN USD 24.85B 3.04B
Bayer BAYN:GR EUR 33.17B 471M
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Cytokinetics CYTK:US USD 76.5M 9.65M
Eisai 4523:JP JPY 266.54B 35.36B
Eli Lilly And LLY:US USD 15.65B 32.2M
Esperion Therapeutics ESPR:US USD 82.34M 70K
Exelixis EXEL:US USD 301.73M 2.79M
Genmab GEN:DC DKK 2.99B 1.04B
Glaxosmithkline GSK:US GBP 22.81B 1.86B
Immunogen IMGN:US USD 103.64M 16.57M
Macrogenics MGNX:US USD 50.05M 831K
Merk MRK:US USD 23B 170M
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Moderna Inc MRNA:US USD 6.81B 5M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Novartis NOVN:VX USD 28.16B 514M
Puma Biotechnology PBYI:US USD 59.99M 3.15M
Seattle Genetics SGEN:US USD 726M 117.48M
Takeda 4502:JP JPY 2.24T 154.91B
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
Xencor XNCR:US USD 90.03M 14.99M
YTE INCY:US USD 1.01B 79.92M